Kayyali Reem, Gebara Shereen Nabhani, Hesso Iman, Funnell Gill, Naik Minal, Mason Thuy, Uddin Mohammed Ahsan, Al-Yaseri Noor, Khayyam Umar, Al-Haddad Teebah, Siva Roshan, Chang John
School of Life Sciences, Pharmacy and Chemistry, Kingston University London, Penrhyn Road, Kingston upon Thames, KT1 2EE, UK.
St. George's Hospital, Blackshaw Road, Greater London, SW17 0QT, UK.
BMC Health Serv Res. 2018 Oct 10;18(1):763. doi: 10.1186/s12913-018-3575-y.
Medication problems among patients with long-term conditions (LTCs) are well documented. Measures to support LTC management include: medicine optimisation services by community pharmacists such as the Medicine Use Review (MUR) service in England, implementation of shared decision making (SDM), and the availability of rapid access clinics in primary care. This study aimed to investigate the experience of patients with LTCs about SDM including medication counselling and their awareness of community pharmacy medication review services.
A mixed research method with a purposive sampling strategy to recruit patients was used. The quantitative phase involved two surveys, each requiring a sample size of 319. The first was related to SDM experience and the second to medication counselling at discharge. Patients were recruited from medical wards at St. George's and Croydon University Hospitals.The qualitative phase involved semi-structured interviews with 18 respiratory patients attending a community rapid access clinic. Interviews were audio-recorded and transcribed verbatim. Thematic analysis using inductive/deductive approaches was employed. Survey results were analysed using descriptive statistics.
The response rate for surveys 1 and 2 survey was 79% (n = 357/450) and 68.5% (240/350) respectively. Survey 1 showed that although 70% of patients had changes made to their medications, only 40% were consulted about them and two-thirds (62.2%) wanted to be involved in SDM. In survey 2, 37.5% of patients thought that medication counselling could be improved. Most patients (88.8%) were interested in receiving the MUR service; however 83% were not aware of it. The majority (57.9%) were interested in receiving their discharge medications from community pharmacies. The interviews generated three themes; lack of patient-centered care and SDM, minimal medication counselling provided and lack of awareness about the MUR service.
Although patients wanted to take part in SDM, yet SDM and medication counselling are not optimally provided. Patients were interested in the MUR service; however there was lack of awareness and referral for this service. The results propose community pharmacy as a new care pathway for medication supply and counselling post discharge. This promotes a change of health policy whereby community-based services are used to enhance the performance of acute hospitals.
长期疾病(LTCs)患者的用药问题已有充分记录。支持LTC管理的措施包括:社区药剂师提供的药物优化服务,如英格兰的用药审查(MUR)服务、实施共同决策(SDM)以及在初级保健机构设立快速就诊诊所。本研究旨在调查LTC患者对SDM(包括用药咨询)的体验及其对社区药房药物审查服务的认知。
采用混合研究方法,通过目的抽样策略招募患者。定量阶段包括两项调查,每项调查所需样本量为319。第一项调查与SDM体验有关,第二项调查与出院时的用药咨询有关。患者从圣乔治医院和克罗伊登大学医院的内科病房招募。定性阶段包括对18名前往社区快速就诊诊所的呼吸科患者进行半结构式访谈。访谈进行了录音并逐字转录。采用归纳/演绎方法进行主题分析。调查结果采用描述性统计进行分析。
调查1和调查2的回复率分别为79%(n = 357/450)和68.5%(240/350)。调查1显示,尽管70%的患者的药物治疗方案有变化,但只有40%的患者就这些变化接受了咨询,三分之二(62.2%)的患者希望参与SDM。在调查2中,37.5%的患者认为用药咨询可以改进。大多数患者(88.8%)对接受MUR服务感兴趣;然而,83%的患者并不了解该服务。大多数(57.9%)患者对从社区药房领取出院药物感兴趣。访谈产生了三个主题:缺乏以患者为中心的护理和SDM、提供的用药咨询极少以及对MUR服务缺乏认知。
尽管患者希望参与SDM,但SDM和用药咨询并未得到最佳提供。患者对MUR服务感兴趣;然而,对该服务缺乏认知且缺乏转诊。结果表明社区药房可作为出院后药物供应和咨询的新护理途径。这促进了卫生政策的变革,即利用社区服务来提高急症医院的绩效。